Alzheimer’s disease is not a rare disease. With an estimated 6.9 million Americans age 65 and older currently living with Alzheimer’s dementia, it far exceeds the threshold that defines a rare condition. In the United States, a rare disease is one that affects fewer than 200,000 people. Alzheimer’s surpasses that number by more than 30 times over.
How Rare Diseases Are Defined
The Orphan Drug Act sets the standard in the U.S.: any disease or condition affecting fewer than 200,000 people qualifies as rare. The National Institutes of Health and the FDA both use this cutoff. Conditions like Huntington’s disease (about 30,000 Americans) and amyotrophic lateral sclerosis, or ALS (roughly 30,000), meet this definition. Alzheimer’s, at 6.9 million cases among older adults alone, is one of the most common neurological diseases in the country.
How Common Alzheimer’s Actually Is
Alzheimer’s is the most common form of dementia, contributing to 60 to 70 percent of all dementia cases worldwide. In 2021, approximately 57 million people globally were living with dementia, with the majority of those cases attributed to Alzheimer’s. In the U.S., it ranks as the 7th leading cause of death overall and the 6th leading cause among adults 65 and older.
The risk rises sharply with age. About 5 percent of people between 65 and 74 have Alzheimer’s dementia. That jumps to 13.2 percent of people aged 75 to 84, and a full third of people 85 and older, at 33.4 percent. As the population ages, these numbers are expected to climb. Projections estimate 13.8 million Americans could be living with Alzheimer’s by 2060 if no major preventive treatments emerge.
The Part of Alzheimer’s That Is Rare
There is one specific form of the disease that does approach rare territory. Early-onset Alzheimer’s, which strikes before age 65, accounts for roughly 5 to 6 percent of all Alzheimer’s cases. Estimates from 2006 placed the number of Americans with early-onset Alzheimer’s between 220,000 and 640,000, putting it in a gray zone around the rare disease threshold depending on which estimate you use. It has a prevalence rate of about 24.2 per 100,000 people in the 45-to-64 age group, making it uncommon by any measure.
Even rarer is familial Alzheimer’s disease, caused by inherited mutations in one of three specific genes. This autosomal dominant form accounts for less than 1 percent of all Alzheimer’s cases. Among people with early-onset Alzheimer’s, only about 11 percent carry one of these mutations. That works out to roughly 0.6 percent of everyone with Alzheimer’s in any form. Familial Alzheimer’s is a genuinely rare disease. It tends to appear earlier, sometimes in a person’s 30s or 40s, and follows a predictable inheritance pattern where a child of an affected parent has a 50 percent chance of inheriting the mutation.
Why the Confusion Exists
The question likely comes up because Alzheimer’s can feel rare from a personal vantage point. Many people don’t encounter it until a parent or grandparent is diagnosed, and the disease was historically underdiagnosed or lumped under the vague label of “senility.” The existence of rare subtypes, particularly familial Alzheimer’s, also muddies the picture. News coverage of genetic breakthroughs often focuses on these rare inherited forms, which can give the impression that the disease itself is uncommon.
The reality is the opposite. Alzheimer’s is so widespread that it represents a major public health burden. Over 60 percent of people with dementia worldwide live in low- and middle-income countries, where diagnosis and care resources are limited. In the U.S., it is one of the few top-10 causes of death for which prevalence is still growing rather than shrinking, driven largely by an aging population.
Sporadic vs. Genetic: What Most Cases Look Like
The vast majority of Alzheimer’s cases are what researchers call “sporadic,” meaning they aren’t caused by a single inherited gene mutation. Sporadic Alzheimer’s develops from a combination of age, genetics (most notably a gene variant called APOE4, which increases risk but doesn’t guarantee the disease), lifestyle factors, and other influences that researchers are still untangling. This is the form that typically appears after age 65 and accounts for well over 90 percent of all cases. Having a family member with sporadic Alzheimer’s modestly increases your own risk, but the inheritance pattern is nothing like the 50/50 odds seen in the rare familial form.